LIST OF TABLES
TABLE 01.GLOBAL GENETIC TESTING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 02.GLOBAL GENETIC TESTING MARKET FOR PREDICTIVE & PRESYMPTOMATIC TESTING, BY REGION, 2019–2027 ($MILLION)
TABLE 03.GLOBAL GENETIC TESTING MARKET FOR CARRIER TESTING, BY REGION, 2019–2027 ($MILLION)
TABLE 04.GLOBAL GENETIC TESTING MARKET FOR PRENATAL AND NEWBORN TESTING, BY REGION, 2019–2027 ($MILLION)
TABLE 05.GLOBAL GENETIC TESTING MARKET FOR DIAGNOSTIC TESTING BY REGION, 2019–2027 ($MILLION)
TABLE 06.GLOBAL GENETIC TESTING MARKET FOR PHARMACOGENOMIC TESTING, BY REGION, 2019–2027 ($MILLION)
TABLE 07.GLOBAL GENETIC TESTING MARKET FOR OTHER TYPES, BY REGION, 2019–2027 ($MILLION)
TABLE 08.GENETIC TESTING MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 09.GENETIC TESTING MARKET FOR CYTOGENETIC TESTING, BY REGION, 2019–2027 ($MILLION)
TABLE 10.GENETIC TESTING MARKET FOR BIOCHEMICAL TESTING, BY REGION, 2019–2027 ($MILLION)
TABLE 11.GENETIC TESTING MARKET FOR MOLECULAR TESTING, BY TYPE, 2019–2027 ($MILLION)
TABLE 12.GENETIC TESTING MARKET FOR DNA SEQUENCING, BY REGION, 2019–2027 ($MILLION)
TABLE 13.GENETIC TESTING MARKET FOR OTHER MOLECULAR TESTS, BY REGION, 2019–2027 ($MILLION)
TABLE 14.GENETIC TESTING MARKET FOR MOLECULAR TESTING, BY REGION, 2019–2027 ($MILLION)
TABLE 15.GENETIC TESTING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 16.GENETIC TESTING MARKET FOR CANCER DIAGNOSIS, BY REGION, 2019–2027 ($MILLION)
TABLE 17.GENETIC TESTING MARKET FOR GENETIC DISEASE DIAGNOSIS, BY REGION, 2019–2027 ($MILLION)
TABLE 18.GENETIC TESTING MARKET FOR CARDIOVASCULAR DISEASE DIAGNOSIS, BY REGION, 2019–2027 ($MILLION)
TABLE 19.GENETIC TESTING MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2027 ($MILLION)
TABLE 20.GENETIC TESTING MARKET REVENUE, BY REGION, 2019–2027 ($MILLION)
TABLE 21.NORTH AMERICA GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 22.NORTH AMERICA GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 23.NORTH AMERICA GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 24.NORTH AMERICA GENETIC TESTING MARKET REVENUE, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 25.U.S. GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 26.U.S. GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 27.U.S. GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 28.CANADA GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 29.CANADA GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 30.CANADA GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 31.MEXICO GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 32.MEXICO GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 33.MEXICO GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 34.EUROPE GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 35.EUROPE GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 36.EUROPE GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 37.EUROPE GENETIC TESTING MARKET REVENUE, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 38.GERMANY GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 39.GERMANY GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 40.GERMANY GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 41.FRANCE GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 42.FRANCE GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 43.FRANCE GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 44.UK GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 45.UK GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 46.UK GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 47.ITALY GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 48.ITALY GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 49.ITALY GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 50.SPAIN GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 51.SPAIN GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 52.SPAIN GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 53.REST OF EUROPE GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 54.REST OF EUROPE GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 55.REST OF EUROPE GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 56.ASIA-PACIFIC GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 57.ASIA-PACIFIC GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 58.ASIA-PACIFIC GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 59.ASIA-PACIFIC GENETIC TESTING MARKET REVENUE, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 60.JAPAN GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 61.JAPAN GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 62.JAPAN GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 63.CHINA GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 64.CHINA GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 65.CHINA GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 66.AUSTRALIA GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 67.AUSTRALIA GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 68.AUSTRALIA GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 69.INDIA GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 70.INDIA GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 71.INDIA GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 72.SOUTH KOREA GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 73.SOUTH KOREA GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 74.SOUTH KOREA GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 75.REST OF ASIA-PACIFIC GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 76.REST OF ASIA-PACIFIC GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 77.REST OF ASIA-PACIFIC GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 78.LAMEA GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 79.LAMEA GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 80.LAMEA GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 81.LAMEA GENETIC TESTING MARKET REVENUE, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 82.BRAZIL GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 83.BRAZIL GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 84.BRAZIL GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 85.SAUDI ARABIA GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 86.SAUDI ARABIA GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 87.SAUDI ARABIA GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 88.SOUTH AFRICA GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 89.SOUTH AFRICA GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 90.SOUTH AFRICA GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 91.REST OF LAMEA GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 92.REST OF LAMEA GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 93.REST OF LAMEA GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 94.ABBOTT: COMPANY SNAPSHOT
TABLE 95.ABBOTT: OERATING SEGMENT
TABLE 96.ABBOTT: PRODUCT PORTFOLIO
TABLE 97.BIO-RAD: COMPANY SNAPSHOT
TABLE 98.BIO-RAD: OPERATING SEGMENTS
TABLE 99.BIO-RAD: PRODUCT PORTFOLIO
TABLE 100.CSL LTD: COMPANY SNAPSHOT
TABLE 101.CSL LTD..: OPERATING SEGMENT
TABLE 102.CSL LTD..: PRODUCT PORTFOLIO
TABLE 103.DANAHER: COMPANY SNAPSHOT
TABLE 104.DANAHER: OPERATING SEGMENTS
TABLE 105.DANAHER: PRODUCT PORTFOLIO
TABLE 106.EUROFINS SCIENTIFIC: COMPANY SNAPSHOT
TABLE 107.EUROFINS SCIENTIFIC.: PRODUCT PORTFOLIO
TABLE 108.ROCHE: COMPANY SNAPSHOT
TABLE 109.ROCHE: OPERATING SEGMENT
TABLE 110.ROCHE: PRODUCT PORTFOLIO
TABLE 111.ILLUMINA: COMPANY SNAPSHOT
TABLE 112.ILLUMINA: OPERATING SEGMENTS
TABLE 113.ILLUMINA: PRODUCT PORTFOLIO
TABLE 114.MYRIAD: COMPANY SNAPSHOT
TABLE 115.MYRIAD: OPERATING SEGMENTS
TABLE 116.MYRIAD: PRODUCT PORTFOLIO
TABLE 117.QIAGEN: COMPANY SNAPSHOT
TABLE 118.QIAGEN: PRODUCT SEGMENT
TABLE 119.QIAGEN: PRODUCT PORTFOLIO
TABLE 120.THERMO FISHER SCIENTIFIC.: COMPANY SNAPSHOT
TABLE 121.THERMO FISHER SCIENTIFIC: PRODUCT SEGMENT
TABLE 122.THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO LIST OF FIGURES
FIGURE 01.SEGMENTATION OF GENETIC TESTING MARKET
FIGURE 02.TOP INVESTMENT POCKETS, 2019
FIGURE 03.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 04.MODERATE BARGAINING POWER OF BUYERS
FIGURE 05.LOW THREAT OF SUBSTITUTION
FIGURE 06.HIGH THREAT OF NEW ENTRANT
FIGURE 07.HIGH COMPETITIVE RIVALRY
FIGURE 08.GLOBAL GENETIC TESTING TOP PLAYER POSITIONING, 2019
FIGURE 09.GLOBAL GENETIC TESTING MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 10.PATENTS REGISTERED/APPROVED IN THE WORLD, 2017-2022
FIGURE 11.PATENTS ANALYSIS BY YEAR, 2017 THROUGH 2022
FIGURE 12.YEAR 2019 PATENT ANALYSIS, BY COUNTRY
FIGURE 13.COMPARATIVE ANALYSIS OF GENETIC TESTING MARKET, BY PREDICTIVE & PRESYMPTOMATIC TESTING, BY REGION, 2019–2027 ($MILLION)
FIGURE 14.COMPARATIVE ANALYSIS OF GENETIC TESTING MARKET, BY CARRIER TESTING, BY REGION, 2019–2027 ($MILLION)
FIGURE 15.COMPARATIVE ANALYSIS OF GENETIC TESTING MARKET, BY PRENATAL AND NEWBORN TESTING, BY REGION, 2019–2027 ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS OF GENETIC TESTING MARKET, BY DIAGNOSTIC TESTING, BY REGION, 2019–2027 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF GENETIC TESTING MARKET, BY PHARMACOGENOMIC TESTING, BY REGION, 2019–2027 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF GENETIC TESTING MARKET, BY OTHER TYPES, BY REGION, 2019–2027 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF GENETIC TESTING MARKET, BY CYTOGENETIC TESTING, BY REGION, 2019–2027 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF GENETIC TESTING MARKET, BY BIOCHEMICAL TESTING, BY REGION, 2019–2027 ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS OF GENETIC TESTING MARKET, BY MOLECULAR TESTING, BY REGION, 2019–2027 ($MILLION)
FIGURE 22.COMPARATIVE ANALYSIS OF GENETIC TESTING MARKET, BY CANCER DIAGNOSIS, BY REGION, 2019–2027 ($MILLION)
FIGURE 23.COMPARATIVE ANALYSIS OF GENETIC TESTING MARKET, BY GENETIC DISEASE DIAGNOSIS, BY REGION, 2019–2027 ($MILLION)
FIGURE 24.COMPARATIVE ANALYSIS OF GENETIC TESTING MARKET, BY CARDIOVASCULAR DISEASE DIAGNOSIS, BY REGION, 2019–2027 ($MILLION)
FIGURE 25.COMPARATIVE ANALYSIS OF GENETIC TESTING MARKET, BY OTHER, BY REGION, 2019–2027 ($MILLION)
FIGURE 26.ABBOTT: NET SALES, 2017–2019 ($MILLION)
FIGURE 27.ABBOTT: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 28.ABBOTT: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 29.BIO-RAD: NET SALES, 2017–2019 ($MILLION)
FIGURE 30.BIO-RAD: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 31.BIO-RAD: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 32.CSL LTD.: NET SALES, 2017–2019 ($MILLION)
FIGURE 33.CSL LTD.: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 34.CSL LTD.: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 35.DANAHER CORPORATION: NET SALES, 2017–2019 ($MILLION)
FIGURE 36.DANAHER CORPORATION: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 37.DANAHER CORPORATION: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 38.EUROFINS SCIENTIFIC.: REVENUE, 2017–2019 ($MILLION)
FIGURE 39.EUROFINS SCIENTIFIC: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 40.ROCHE: NET SALES, 2017–2019 ($MILLION)
FIGURE 41.ROCHE: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 42.ROCHE: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 43.ILLUMINA: NET SALES, 2017–2019 ($MILLION)
FIGURE 44.ILLUMINA: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 45.ILLUMINA: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 46.MYRIAD: NET SALES, 2018–2020 ($MILLION)
FIGURE 47.MYRIAD: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 48.QIAGEN: NET SALES, 2017–2019 ($MILLION)
FIGURE 49.QIAGEN: REVENUE SHARE, BY PRODUCT, 2019 (%)
FIGURE 50.QIAGEN: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 51.THERMO FISHER SCIENTIFIC, INC.: NET SALES, 2017–2019 ($MILLION)
FIGURE 52.THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 53.THERMO FISHER SCIENTIFIC. REVENUE SHARE, BY REGION, 2019 (%